Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) EBITDA Margin (2016)

Historic EBITDA Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5737.96%.

  • Microbot Medical's EBITDA Margin rose 212345800.0% to 5737.96% in Q3 2016 from the same period last year, while for Sep 2016 it was 25453.42%, marking a year-over-year decrease of 215457100.0%. This contributed to the annual value of 31415.32% for FY2015, which is N/A changed from last year.
  • Per Microbot Medical's latest filing, its EBITDA Margin stood at 5737.96% for Q3 2016, which was up 212345800.0% from 30309.28% recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's EBITDA Margin registered a high of 826.99% during Q1 2012, and its lowest value of 42674.62% during Q1 2015.
  • For the 5-year period, Microbot Medical's EBITDA Margin averaged around 18705.6%, with its median value being 18852.32% (2013).
  • As far as peak fluctuations go, Microbot Medical's EBITDA Margin plummeted by -282068700bps in 2015, and later skyrocketed by 212345800bps in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's EBITDA Margin stood at 2917.39% in 2012, then tumbled by -582bps to 19907.16% in 2013, then skyrocketed by 94bps to 1101.83% in 2014, then crashed by -2560bps to 29308.7% in 2015, then soared by 80bps to 5737.96% in 2016.
  • Its EBITDA Margin stands at 5737.96% for Q3 2016, versus 30309.28% for Q2 2016 and 42366.93% for Q1 2016.